Robert Hurwitz

Fundador en

The Coral Co.

Finance

Health Services

Health Technology

Perfil

Robert Hurwitz is the founder of The Coral Co. which was founded in 1987.
He is currently the Chairman of BioMendics LLC and a Trustee at The MetroHealth System, Inc. where he started in 2017.
He was previously an Advisor at Edgewater Capital Partners.

Cargos activos de Robert Hurwitz

Empresas	Cargo	Inicio
The Coral Co. The Coral Co. Real Estate DevelopmentFinance Operates as a commercial and residential real estate developer	Fundador	01/01/1987
The MetroHealth System, Inc. The MetroHealth System, Inc. Hospital/Nursing ManagementHealth Services Provides health care services	Director/Miembro de la Junta	01/01/2017
BioMendics LLC BioMendics LLC BiotechnologyHealth Technology Provides research and treatment of acute wounds, burns & inflammatory skin conditions	Presidente	-

Todos los cargos activos de Robert Hurwitz

Antiguos cargos conocidos de Robert Hurwitz.

Empresas	Cargo	Fin
Edgewater Capital Partners Edgewater Capital Partners Investment ManagersFinance Edgewater Capital Partners invests in lower middle market companies located in the Unites States with an EBITDA of less than USD 25 million and revenues of less than USD 100 million. The firm focuses on specialty industrials, life science, advanced materials and specialty chemicals. It participates in MBO transactions with an investment size of up to USD 50 million.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Robert Hurwitz.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Robert Hurwitz.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Edgewater Capital Partners Edgewater Capital Partners Investment ManagersFinance Edgewater Capital Partners invests in lower middle market companies located in the Unites States with an EBITDA of less than USD 25 million and revenues of less than USD 100 million. The firm focuses on specialty industrials, life science, advanced materials and specialty chemicals. It participates in MBO transactions with an investment size of up to USD 50 million.	Finance
The MetroHealth System, Inc. The MetroHealth System, Inc. Hospital/Nursing ManagementHealth Services Provides health care services	Health Services
The Coral Co. The Coral Co. Real Estate DevelopmentFinance Operates as a commercial and residential real estate developer	Finance
BioMendics LLC BioMendics LLC BiotechnologyHealth Technology Provides research and treatment of acute wounds, burns & inflammatory skin conditions	Health Technology